Updated

Updated · CBS New York · Aug 22

Alayna Riozzi-Bodine Stays Cancer-Free 2 Years After Recurrent Hodgkin's Lymphoma Treatment

Updated

Updated · CBS New York · Aug 22

Alayna Riozzi-Bodine Stays Cancer-Free 2 Years After Recurrent Hodgkin's Lymphoma Treatment

1 articles · Updated · CBS New York · Aug 22

July scans showed Alayna Riozzi-Bodine remains cancer-free two years after finishing treatment in July 2024 for recurrent Hodgkin's lymphoma.
Diagnosed with Stage 2 disease at 17 in 2021, the New Jersey athlete first underwent eight chemotherapy sessions and was declared cancer-free during her freshman year of college.
Less than a year later, the cancer returned more aggressively, leading to immunotherapy, more chemotherapy and a stem cell transplant followed by six weeks in isolation.
Now a college graduate, Riozzi-Bodine is pursuing pediatric oncology nursing and runs the Alayna Jayne Foundation, which supports teen cancer patients and advocates cold-cap use.
Doctors said she will keep getting regular scans, while the risk of recurrence becomes extremely low if Hodgkin's lymphoma patients stay cancer-free for five years.

Sources

Why did a devastating cancer relapse ultimately inspire a young survivor to dedicate her life to the ward that saved her?

What hidden medical dangers do young cancer survivors still face decades after aggressive treatments finally cure their disease?

How did a teen's risky push for an unapproved hair-loss treatment alter pediatric lymphoma care at a major cancer center?

1 total